Epidemiologic data of primary glomerular diseases in western France

Slides:



Advertisements
Similar presentations
Copyright © 2015 by the American Osteopathic Association.
Advertisements

Management of IgA nephropathy: Evidence-based recommendations
Volume 81, Issue 2, Pages (January 2012)
Volume 62, Issue 3, Pages (September 2002)
Current status of end-stage renal disease care in India and Pakistan
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use  Mei-Ling Blank, Lianne.
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
End-stage renal disease in developing countries
Volume 83, Issue 3, Pages (March 2013)
Volume 93, Issue 3, Pages (March 2018)
From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria  Paul E. De Jong, Barry M. Brenner  Kidney International 
Current status of end-stage renal disease care in India and Pakistan
Expression of the C-C chemokine receptor 5 in human kidney diseases1
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
Volume 86, Issue 6, Pages (December 2014)
Volume 76, Issue 5, Pages (September 2009)
Volume 62, Issue 3, Pages (September 2002)
Volume 80, Issue 10, Pages (November 2011)
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
G protein β3 subunit C825T polymorphism in primary IgA nephropathy
Volume 64, Issue 3, Pages (September 2003)
Burden of chronic kidney disease: North Africa
Nat. Rev. Nephrol. doi: /nrneph
Francesco Paolo Schena  Kidney International 
Volume 76, Issue 7, Pages (October 2009)
End-stage renal disease in living kidney donors
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Outcome study of renal biopsy patients in Okinawa, Japan
Comorbidity and confounding in end-stage renal disease
Enlarged nephrons and severe nondiabetic nephropathy in hepatocyte nuclear factor-1β (HNF-1β) mutation carriers  Jørn V. Sagen, Leif Bostad, Pål R. Njølstad,
Volume 70, Issue 11, Pages (December 2006)
Volume 78, Issue 5, Pages (September 2010)
Volume 67, Issue 4, Pages (April 2005)
A novel classification for IgA nephropathy
The epidemiology of chronic kidney disease
Volume 70, Issue 12, Pages (December 2006)
Frank Eitner, Jürgen Floege  Kidney International 
Volume 76, Issue 5, Pages (September 2009)
Volume 61, Issue 1, Pages (January 2002)
HIV-related nephropathy: A South African perspective
Volume 72, Issue 12, Pages (December 2007)
Methods for guideline development
Volume 92, Issue 2, Pages (August 2017)
Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis  Gil A. Cu, Sergio.
Racial disparities in access to transplantation: a tough nut to crack
Volume 76, Issue 8, Pages (October 2009)
Volume 85, Issue 1, Pages (January 2014)
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Volume 69, Issue 8, Pages (April 2006)
Volume 71, Issue 4, Pages (February 2007)
Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker 
Volume 55, Pages S3-S16 (June 1999)
The Danish Renal Biopsy Register
Volume 80, Issue 10, Pages (November 2011)
The changing face of childhood nephrotic syndrome
Membranous nephropathy: recent travels and new roads ahead
Dana V. Rizk, David G. Warnock  Kidney International 
Volume 80, Issue 9, Pages (November 2011)
Volume 55, Pages S41-S46 (June 1999)
Prediction in idiopathic membranous nephropathy
Volume 55, Issue 5, Pages (May 1999)
Absolute renal biopsy diagnosis frequencies of the most common glomerular disease subtypes according to patient age category. Absolute renal biopsy diagnosis.
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Incident cases of ESRD secondary to heroin-associated nephropathy, membranoproliferative glomerulonephritis type 1, HIV infection, and focal segmental.
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Relative renal biopsy diagnosis frequencies of the most common glomerular disease subtypes according to patient age category and typical mode of clinical.
Presentation transcript:

Epidemiologic data of primary glomerular diseases in western France Pierre Simon, Marie-Paule Ramee, Rehouni Boulahrouz, Corina Stanescu, Christophe Charasse, K.I.M. Seng aNG, Françoise Leonetti, Gérard Cam, Eric Laruelle, Valérie Autuly, Nathalie Rioux  Kidney International  Volume 66, Issue 3, Pages 905-908 (September 2004) DOI: 10.1111/j.1523-1755.2004.00834.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Renal biopsy indications according to period. Abbreviations are: ARF, acute renal failure; CRF, chronic renal failure; NS, nephrotic syndrome; P, proteinuria; H, hematuria; A, period A (1976 to 1985); B, period B (1986 to 1995); C, period C (1996 to 2002) (N = 663 renal biopsies during the period). Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Evolution of mean age at the time of renal biopsy years. Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Annual incidence of primary glomerular disease (PGD) according to period and gender (incidence number/per million). Abbbreviations are: IsAN, IgA nephropathy (Bergers' disease); MN, membranous nephropathy; MC, minimal change; A, period A. Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Annual incidence of primary glomerular disease (PGD) according to period and gender (incidence number/per million). Abbreviations are: MPGN, membranoproliferative glomerulonephritis type 1; acute PGN, poststreptococcal acute glomerulonephritis; crescentic PGN, idiopathic crescentic proliferative glomerulonephritis; A, period A. **P < 0.01; *P <0.05; +++P < 0.001 with period A. Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Annual incidence of end-stage renal disease (ESRD) due to biopsied primary glomerular disease (PGD) according to period (incidence number/per million). Abbreviations are: Cresc. PGN, idiopathic crescentric proliferative glomerulonephritis; IgAN, IgA nephropathy; other, focal segmental glomerular sclerosis (with and without nephrotic syndrome, membranous nephropathy, membranoproliferative glomerulonephritis. ++P < 0.01. Kidney International 2004 66, 905-908DOI: (10.1111/j.1523-1755.2004.00834.x) Copyright © 2004 International Society of Nephrology Terms and Conditions